{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:49:00Z","timestamp":1793972940806,"version":"4.8.0"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000533"],"award-info":[{"award-number":["32000533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-024-01589-8","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:02:27Z","timestamp":1723788147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives"],"prefix":"10.1186","volume":"17","author":[{"given":"Chenliang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"9","key":"1589_CR1","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","volume":"31","author":"T Tsang","year":"2021","unstructured":"Tsang T, Davis CI, Brady DC. Copper biology. Curr Biol. 2021;31(9):R421\u20137.","journal-title":"Curr Biol"},{"issue":"2","key":"1589_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","volume":"14","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol. 2010;14(2):211\u20137.","journal-title":"Curr Opin Chem Biol"},{"key":"1589_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtemb.2016.02.006","volume":"35","author":"M Bost","year":"2016","unstructured":"Bost M, Houdart S, Oberli M, Kalonji E, Huneau JF, Margaritis I. Dietary copper and human health: current evidence and unresolved issues. J Trace Elem Med Biol. 2016;35:107\u201315.","journal-title":"J Trace Elem Med Biol"},{"issue":"4","key":"1589_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0043-1771465","volume":"43","author":"M Wungjiranirun","year":"2023","unstructured":"Wungjiranirun M, Sharzehi K. Wilson\u2019s disease. Semin Neurol. 2023;43(4):626\u201333.","journal-title":"Semin Neurol"},{"issue":"2","key":"1589_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/07853899609092936","volume":"28","author":"Z T\u00fcmer","year":"1996","unstructured":"T\u00fcmer Z, Horn N. Menkes disease: recent advances and new insights into copper metabolism. Ann Med. 1996;28(2):121\u20139.","journal-title":"Ann Med"},{"key":"1589_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102\u201313.","journal-title":"Nat Rev Cancer"},{"key":"1589_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2190001","volume":"219","author":"B Halliwell","year":"1984","unstructured":"Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984;219:1\u201314.","journal-title":"Biochem J"},{"key":"1589_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.841814","volume":"9","author":"V Oliveri","year":"2022","unstructured":"Oliveri V. Selective targeting of cancer cells by copper ionophores: an overview. Front Mol Biosci. 2022;9: 841814.","journal-title":"Front Mol Biosci"},{"key":"1589_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"1589_CR10","first-page":"359","volume":"13","author":"I Scheiber","year":"2013","unstructured":"Scheiber I, Dringen R, Mercer JF. Copper: effects of deficiency and overload. Met Ions Life Sci. 2013;13:359\u201387.","journal-title":"Met Ions Life Sci"},{"key":"1589_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1301\/nr.2007.jul.335\u2013340","volume":"65","author":"MD Knutson","year":"2007","unstructured":"Knutson MD. Steap proteins: implications for iron and copper metabolism. Nutr Rev. 2007;65:335\u201340.","journal-title":"Nutr Rev"},{"key":"1589_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.febslet.2008.05.010","volume":"582","author":"S Wyman","year":"2008","unstructured":"Wyman S, Simpson RJ, McKie AT, Sharp PA. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett. 2008;582:1901\u20136.","journal-title":"FEBS Lett"},{"issue":"21","key":"1589_CR13","doi-asserted-by":"publisher","first-page":"jcs240523","DOI":"10.1242\/jcs.240523","volume":"134","author":"S Lutsenko","year":"2021","unstructured":"Lutsenko S. Dynamic and cell-specific transport networks for intracellular copper ions. J Cell Sci. 2021;134(21):jcs240523.","journal-title":"J Cell Sci"},{"issue":"3","key":"1589_CR14","doi-asserted-by":"publisher","first-page":"846S","DOI":"10.1093\/ajcn\/88.3.846S","volume":"88","author":"B L\u00f6nnerdal","year":"2008","unstructured":"L\u00f6nnerdal B. Intestinal regulation of copper homeostasis: a developmental perspective. Am J Clin Nutr. 2008;88(3):846S-S850.","journal-title":"Am J Clin Nutr"},{"issue":"5 Suppl","key":"1589_CR15","doi-asserted-by":"publisher","first-page":"965S","DOI":"10.1093\/ajcn\/67.5.965S","volume":"67","author":"MC Linder","year":"1998","unstructured":"Linder MC, Wooten L, Cerveza P, Cotton S, Shulze R, Lomeli N. Copper transport. Am J Clin Nutr. 1998;67(5 Suppl):965S-971S.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1589_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/cphy.c170045","volume":"8","author":"C Doguer","year":"2018","unstructured":"Doguer C, Ha JH, Collins JF. Intersection of iron and copper metabolism in the mammalian intestine and liver. Compr Physiol. 2018;8(4):1433\u201361.","journal-title":"Compr Physiol"},{"key":"1589_CR17","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1016\/S0021-9258(18)83589-X","volume":"264","author":"JH Freedman","year":"1989","unstructured":"Freedman JH, Ciriolo MR, Peisach J. The role of glutathione in copper metabolism and toxicity. J Biol Chem. 1989;264:5598\u2013605.","journal-title":"J Biol Chem"},{"issue":"6","key":"1589_CR18","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.040461197","volume":"97","author":"PC Wong","year":"2000","unstructured":"Wong PC, Waggoner D, Subramaniam JR, et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu\/Zn superoxide dismutase. Proc Natl Acad Sci USA. 2000;97(6):2886\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"1589_CR19","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1038\/s41388-019-0839-x","volume":"38","author":"ML Gomez","year":"2019","unstructured":"Gomez ML, Shah N, Kenny TC, Jenkins EC Jr, Germain D. SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation. Oncogene. 2019;38(29):5751\u201365.","journal-title":"Oncogene"},{"key":"1589_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1073\/pnas.0336230100","volume":"100","author":"I Hamza","year":"2003","unstructured":"Hamza I, Prohaska J, Gitlin JD. Essential role for Atox1 in the copper-mediated intracellular trafficking of the menkes ATPase. Proc Natl Acad Sci USA. 2003;100:1215\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1589_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-biochem-030409-143539","volume":"79","author":"NJ Robinson","year":"2010","unstructured":"Robinson NJ, Winge DR. Copper metallochaperones. Annu Rev Biochem. 2010;79:537\u201362.","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"1589_CR22","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1073\/pnas.111058498","volume":"98","author":"I Hamza","year":"2001","unstructured":"Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci USA. 2001;98(12):6848\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1589_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.abb.2007.04.021","volume":"463","author":"S La Fontaine","year":"2007","unstructured":"La Fontaine S, Mercer JF. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys. 2007;463(2):149\u201367.","journal-title":"Arch Biochem Biophys"},{"issue":"48","key":"1589_CR24","doi-asserted-by":"publisher","first-page":"36552","DOI":"10.1074\/jbc.M606839200","volume":"281","author":"PA Cobine","year":"2006","unstructured":"Cobine PA, Pierrel F, Bestwick ML, Winge DR. Mitochondrial matrix copper complex used in metallation of cytochrome oxidase and superoxide dismutase. J Biol Chem. 2006;281(48):36552\u20139.","journal-title":"J Biol Chem"},{"key":"1589_CR25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1074\/jbc.RA117.000265","volume":"293","author":"A Boulet","year":"2018","unstructured":"Boulet A, Vest KE, Maynard MK, Gammon MG, Russell AC, Mathews AT, et al. The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem. 2018;293:1887\u201396.","journal-title":"J Biol Chem"},{"issue":"11","key":"1589_CR26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1039\/C7MT00221A","volume":"9","author":"ZN Baker","year":"2017","unstructured":"Baker ZN, Cobine PA, Leary SC. The mitochondrion: a central architect of copper homeostasis. Metallomics. 2017;9(11):1501\u201312.","journal-title":"Metallomics"},{"issue":"1","key":"1589_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tem.2022.11.001","volume":"34","author":"NM Garza","year":"2023","unstructured":"Garza NM, Swaminathan AB, Maremanda KP, Zulkifli M, Gohil VM. Mitochondrial copper in human genetic disorders. Trends Endocrinol Metab. 2023;34(1):21\u201333.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1589_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/iub.50","volume":"60","author":"D Horn","year":"2008","unstructured":"Horn D, Barrientos A. Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life. 2008;60(7):421\u20139.","journal-title":"IUBMB Life"},{"key":"1589_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2020.126629","volume":"62","author":"Y Feng","year":"2020","unstructured":"Feng Y, Zeng JW, Ma Q, Zhang S, Tang J, Feng JF. Serum copper and zinc levels in breast cancer: a meta-analysis. J Trace Elem Med Biol. 2020;62: 126629.","journal-title":"J Trace Elem Med Biol"},{"key":"1589_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.770115","volume":"9","author":"F Duan","year":"2021","unstructured":"Duan F, Li J, Huang J, Hua X, Song C, Wang L, et al. Establishment and validation of prognostic nomograms based on serum copper level for patients with early-stage triple-negative breast cancer. Front Cell Dev Biol. 2021;9: 770115.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1589_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000499261","volume":"14","author":"SAK Saleh","year":"2020","unstructured":"Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM. Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr Urol. 2020;14(1):44\u20139.","journal-title":"Curr Urol"},{"key":"1589_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2022.127061","volume":"74","author":"L Zhang","year":"2022","unstructured":"Zhang L, Shao J, Tan SW, Ye HP, Shan XY. Association between serum copper\/zinc ratio and lung cancer: a systematic review with meta-analysis. J Trace Elem Med Biol. 2022;74: 127061.","journal-title":"J Trace Elem Med Biol"},{"key":"1589_CR33","doi-asserted-by":"publisher","first-page":"BSR20180161","DOI":"10.1042\/BSR20180161","volume":"38","author":"M Zhang","year":"2018","unstructured":"Zhang M, Shi M, Zhao Y. Association between serum copper levels and cervical cancer risk: a meta-analysis. Biosci Rep. 2018;38:BSR20180161.","journal-title":"Biosci Rep"},{"key":"1589_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11255-009-9583-4","volume":"42","author":"H Mazdak","year":"2010","unstructured":"Mazdak H, Yazdekhasti F, Movahedian A, Mirkheshti N, Shafieian M. The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group. Int Urol Nephrol. 2010;42:89\u201393.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1589_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12011-016-0768-2","volume":"175","author":"AK Baltaci","year":"2017","unstructured":"Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Elem Res. 2017;175(1):57\u201364.","journal-title":"Biol Trace Elem Res"},{"key":"1589_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/2319-4170.132888","volume":"37","author":"M Baharvand","year":"2014","unstructured":"Baharvand M, Manifar S, Akkafan R, Mortazavi H, Sabour S. Serum levels of ferritin, copper, and zinc in patients with oral cancer. Biomed J. 2014;37:331\u20136.","journal-title":"Biomed J"},{"key":"1589_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1746-160X-2-33","volume":"2","author":"SS Khanna","year":"2006","unstructured":"Khanna SS, Karjodkar FR. Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med. 2006;2:33.","journal-title":"Head Face Med"},{"issue":"7","key":"1589_CR38","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1128\/MCB.05722-11","volume":"32","author":"ML Turski","year":"2012","unstructured":"Turski ML, Brady DC, Kim HJ, et al. A novel role for copper in Ras\/mitogen-activated protein kinase signaling. Mol Cell Biol. 2012;32(7):1284\u201395.","journal-title":"Mol Cell Biol"},{"key":"1589_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady DC, Crowe MS, Turski ML, Hobbs GA, Yao X, Chaikuad A, et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 2014;509:492\u20136.","journal-title":"Nature"},{"issue":"22","key":"1589_CR40","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-16-1190","volume":"77","author":"DC Brady","year":"2017","unstructured":"Brady DC, Crowe MS, Greenberg DN, Counter CM. Copper chelation inhibits BRAFV600E-driven melanomagenesis and counters resistance to BRAFV600E and MEK1\/2 inhibitors. Cancer Res. 2017;77(22):6240\u201352.","journal-title":"Cancer Res"},{"key":"1589_CR41","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1073\/pnas.1817473116","volume":"116","author":"V Shanbhag","year":"2019","unstructured":"Shanbhag V, Jasmer-McDonald K, Zhu S, Martin AL, Gudekar N, Khan A, et al. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis. Proc Natl Acad Sci USA. 2019;116:6836\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1589_CR42","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/carcin\/bgu072","volume":"35","author":"GP Nagaraju","year":"2014","unstructured":"Nagaraju GP, Dontula R, El-Rayes BF, Lakka SS. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. Carcinogenesis. 2014;35(5):967\u201373.","journal-title":"Carcinogenesis"},{"issue":"329","key":"1589_CR43","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.2004870","volume":"7","author":"G MacDonald","year":"2014","unstructured":"MacDonald G, Nalvarte I, Smirnova T, et al. Memo is a copper-dependent redox protein with an essential role in migration and metastasis. Sci Signal. 2014;7(329):ra56.","journal-title":"Sci Signal"},{"key":"1589_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2023.112335","volume":"247","author":"X Zhang","year":"2023","unstructured":"Zhang X, Walke G, Wittung-Stafshede P. Memo1 reduces copper-mediated reactive oxygen species in breast cancer cells. J Inorg Biochem. 2023;247: 112335.","journal-title":"J Inorg Biochem"},{"key":"1589_CR45","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1529\/biophysj.105.079988","volume":"91","author":"V Sivaraja","year":"2006","unstructured":"Sivaraja V, Kumar TK, Rajalingam D, Graziani I, Prudovsky I, Yu C. Copper binding affinity of S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex. Biophys J. 2006;91:1832\u201343.","journal-title":"Biophys J"},{"key":"1589_CR46","doi-asserted-by":"publisher","first-page":"34158","DOI":"10.18632\/oncotarget.5779","volume":"6","author":"DC Rigiracciolo","year":"2015","unstructured":"Rigiracciolo DC, Scarpelli A, Lappano R, Pisano A, Santolla MF, De Marco P, et al. Copper activates HIF-1\u03b1\/GPER\/VEGF signalling in cancer cells. Oncotarget. 2015;6:34158\u201377.","journal-title":"Oncotarget"},{"key":"1589_CR47","first-page":"4854","volume":"62","author":"Q Pan","year":"2002","unstructured":"Pan Q, Kleer CG, Golen KL, Irani J, Bottema KM, Bias C, et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854\u20139.","journal-title":"Cancer Res"},{"key":"1589_CR48","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1073\/pnas.1231994100","volume":"100","author":"L Mandinov","year":"2003","unstructured":"Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci USA. 2003;100:6700\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1589_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cancers1010023","volume":"1","author":"M Wangpaichitr","year":"2009","unstructured":"Wangpaichitr M, Wu C, You M, Maher JC, Dinh V, Feun LG, et al. N\u2019, N\u2019-Dimethyl-N\u2032, N\u2032-bis(phenylcarbonothioyl) propanedihydrazide (elesclomol) selectively kills cisplatin resistant lung cancer cells through reactive oxygen species (ROS). Cancers. 2009;1:23\u201338.","journal-title":"Cancers"},{"key":"1589_CR50","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1080\/21655979.2022.2038434","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Guan X, Wang M, Wang N, Chen Y, Li B, et al. Disulfiram\/copper induces antitumor activity against gastric cancer via the ROS\/MAPK and NPL4 pathways. Bioengineered. 2022;13:6579\u201389.","journal-title":"Bioengineered"},{"key":"1589_CR51","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3892\/ol.2020.12237","volume":"20","author":"JH Lee","year":"2020","unstructured":"Lee JH, Cho YS, Jung KH, Park JW, Lee KH. Genipin enhances the antitumor effect of elesclomol in A549 lung cancer cells by blocking uncoupling protein-2 and stimulating reactive oxygen species production. Oncol Lett. 2020;20:374.","journal-title":"Oncol Lett"},{"key":"1589_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CMR.0b013e328334131d","volume":"20","author":"BW Morrison","year":"2010","unstructured":"Morrison BW, Doudican NA, Patel KR, Orlow SJ. Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Melanoma Res. 2010;20:11\u201320.","journal-title":"Melanoma Res"},{"key":"1589_CR53","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1248\/bpb.b21-00466","volume":"44","author":"Y Ren","year":"2021","unstructured":"Ren Y, Lin Y, Chen J, Jin Y. Disulfiram chelated with copper promotes apoptosis in osteosarcoma via ROS\/mitochondria pathway. Biol Pharm Bull. 2021;44:1557\u201364.","journal-title":"Biol Pharm Bull"},{"key":"1589_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-021-02031-4","volume":"40","author":"M Buccarelli","year":"2021","unstructured":"Buccarelli M, D\u2019Alessandris QG, Matarrese P, Mollinari C, Signore M, Cappannini A, et al. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J Exp Clin Cancer Res. 2021;40:228.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"1589_CR55","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao W, Huang Z, Duan J, Nice EC, Lin J, Huang C. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021;15(12):3527\u201344.","journal-title":"Mol Oncol"},{"issue":"7682","key":"1589_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, Sviderskiy VO, Terzi EM, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017;551(7682):639\u201343.","journal-title":"Nature"},{"issue":"7","key":"1589_CR57","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19(7):1982\u201396.","journal-title":"Autophagy"},{"key":"1589_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2022.100483","volume":"25","author":"S Javadov","year":"2022","unstructured":"Javadov S. Mitochondria and ferroptosis. Curr Opin Physiol. 2022;25: 100483.","journal-title":"Curr Opin Physiol"},{"key":"1589_CR59","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X. Role of mitochondria in ferroptosis. Mol Cell. 2019;73:354-363.e3.","journal-title":"Mol Cell"},{"key":"1589_CR60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283:65\u201387.","journal-title":"Toxicology"},{"key":"1589_CR61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41419-023-05778-0","volume":"14","author":"G Wang","year":"2023","unstructured":"Wang G, Qin S, Chen L, Geng H, Zheng Y, Xia C, et al. Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling. Cell Death Dis. 2023;14:292.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1589_CR62","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res. 2023;42(1):142.","journal-title":"J Exp Clin Cancer Res"},{"key":"1589_CR63","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1589_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.110236","volume":"191","author":"H Wu","year":"2020","unstructured":"Wu H, Guo H, Liu H, et al. Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways. Ecotoxicol Environ Saf. 2020;191: 110236.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1589_CR65","first-page":"1359164","volume":"2020","author":"H Liu","year":"2020","unstructured":"Liu H, Guo H, Jian Z, et al. Copper induces oxidative stress and apoptosis in the mouse liver. Oxid Med Cell Longev. 2020;2020:1359164.","journal-title":"Oxid Med Cell Longev"},{"key":"1589_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110048","volume":"126","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhou Q, Feng X, et al. Disulfiram\/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. Biomed Pharmacother. 2020;126: 110048.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1589_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jb\/mvab045","volume":"170","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang X, Lin L, et al. The disulfiram\/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS\/JNK signalling pathway. J Biochem. 2021;170(2):275\u201387.","journal-title":"J Biochem"},{"key":"1589_CR68","doi-asserted-by":"publisher","first-page":"33444","DOI":"10.1038\/srep33444","volume":"6","author":"AM Santoro","year":"2016","unstructured":"Santoro AM, Monaco I, Attanasio F, et al. Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study. Sci Rep. 2016;6:33444.","journal-title":"Sci Rep"},{"issue":"1","key":"1589_CR69","first-page":"81","volume":"37","author":"Y Xiao","year":"2010","unstructured":"Xiao Y, Chen DI, Zhang X, et al. Molecular study on copper-mediated tumor proteasome inhibition and cell death. Int J Oncol. 2010;37(1):81\u20137.","journal-title":"Int J Oncol"},{"key":"1589_CR70","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1021\/jm049568z","volume":"47","author":"D Cen","year":"2004","unstructured":"Cen D, Brayton D, Shahandeh B, Meyskens FL Jr, Farmer PJ. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem. 2004;47:6914\u201320.","journal-title":"J Med Chem"},{"key":"1589_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2019.110158","volume":"190","author":"F Wan","year":"2020","unstructured":"Wan F, Zhong G, Ning Z, et al. Long-term exposure to copper induces autophagy and apoptosis through oxidative stress in rat kidneys. Ecotoxicol Environ Saf. 2020;190: 110158.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"43","key":"1589_CR72","doi-asserted-by":"publisher","first-page":"98127","DOI":"10.1007\/s11356-023-29397-6","volume":"30","author":"X Wang","year":"2023","unstructured":"Wang X, Yang F, Tian X, et al. Toxic effects of copper on duck cerebrum: a crucial role of oxidative stress and endoplasmic reticulum quality control. Environ Sci Pollut Res Int. 2023;30(43):98127\u201338.","journal-title":"Environ Sci Pollut Res Int"},{"key":"1589_CR73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"T Tsang","year":"2020","unstructured":"Tsang T, Posimo JM, Gudiel AA, Cicchini M, Feldser DM, Brady DC. Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat Cell Biol. 2020;22:412\u201324.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1589_CR74","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41420-023-01641-5","volume":"9","author":"S Tang","year":"2023","unstructured":"Tang S, Liang C, Hou W, et al. ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis. Cell Death Discov. 2023;9(1):344.","journal-title":"Cell Death Discov"},{"issue":"2","key":"1589_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12568","volume":"52","author":"Z Yu","year":"2019","unstructured":"Yu Z, Zhou R, Zhao Y, Pan Y, Liang H, Zhang JS, et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 2019;52(2): e12568.","journal-title":"Cell Prolif"},{"key":"1589_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102284","volume":"52","author":"F Xia","year":"2022","unstructured":"Xia F, Fu Y, Xie H, Chen Y, Fang D, Zhang W, et al. Suppression of ATG4B by copper inhibits autophagy and involves in Mallory body formation. Redox Biol. 2022;52: 102284.","journal-title":"Redox Biol"},{"issue":"4","key":"1589_CR77","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/acs.jafc.1c07927","volume":"70","author":"J Liao","year":"2022","unstructured":"Liao J, Hu Z, Li Q, et al. Endoplasmic reticulum stress contributes to copper-induced pyroptosis via regulating the IRE1\u03b1-XBP1 pathway in pig jejunal epithelial cells. J Agric Food Chem. 2022;70(4):1293\u2013303.","journal-title":"J Agric Food Chem"},{"key":"1589_CR78","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ecoenv.2019.02.069","volume":"174","author":"J Liao","year":"2019","unstructured":"Liao J, Yang F, Tang Z, et al. Inhibition of Caspase-1-dependent pyroptosis attenuates copper-induced apoptosis in chicken hepatocytes. Ecotoxicol Environ Saf. 2019;174:110\u20139.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1589_CR79","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fphar.2017.00804","volume":"8","author":"YJ Ren","year":"2017","unstructured":"Ren YJ, Wang XH, Ji C, et al. Silencing of NAC1 expression induces cancer cells oxidative stress in hypoxia and potentiates the therapeutic activity of elesclomol. Front Pharmacol. 2017;8:804.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1589_CR80","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-009-0470-6","volume":"121","author":"Y Qu","year":"2010","unstructured":"Qu Y, Wang J, Sim MS, et al. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Res Treat. 2010;121(2):311\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1589_CR81","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","volume":"7","author":"JR Kirshner","year":"2008","unstructured":"Kirshner JR, He S, Balasubramanyam V, et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther. 2008;7(8):2319\u201327.","journal-title":"Mol Cancer Ther"},{"issue":"35","key":"1589_CR82","doi-asserted-by":"publisher","first-page":"56933","DOI":"10.18632\/oncotarget.10921","volume":"7","author":"SY Kwan","year":"2016","unstructured":"Kwan SY, Cheng X, Tsang YT, et al. Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells. Oncotarget. 2016;7(35):56933\u201343.","journal-title":"Oncotarget"},{"issue":"27","key":"1589_CR83","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1038\/s41388-022-02364-0","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Yang J, Zhang Q, et al. Copper ionophore elesclomol selectively targets GNAQ\/11-mutant uveal melanoma. Oncogene. 2022;41(27):3539\u201353.","journal-title":"Oncogene"},{"issue":"5","key":"1589_CR84","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.dnarep.2012.02.003","volume":"11","author":"E Alli","year":"2012","unstructured":"Alli E, Ford JM. Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol. DNA Repair (Amst). 2012;11(5):522\u20134.","journal-title":"DNA Repair (Amst)"},{"issue":"6","key":"1589_CR85","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1002\/jcb.28342","volume":"120","author":"G Albayrak","year":"2019","unstructured":"Albayrak G, Korkmaz FD, Tozcu D, Dogan TI. The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol. J Cell Biochem. 2019;120(6):10564\u201371.","journal-title":"J Cell Biochem"},{"issue":"10","key":"1589_CR86","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai M, Vo NH, Shin Ogawa L, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med. 2012;52(10):2142\u201350.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"1589_CR87","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300980R","volume":"37","author":"H Wen","year":"2023","unstructured":"Wen H, Qu C, Wang Z, et al. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT\/mTOR pathway in prostate cancer. FASEB J. 2023;37(9): e23145.","journal-title":"FASEB J"},{"key":"1589_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112159","volume":"134","author":"N Huang","year":"2024","unstructured":"Huang N, Feng Y, Liu Y, et al. Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis. Int Immunopharmacol. 2024;134: 112159.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1589_CR89","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/pros.21247","volume":"71","author":"J Lin","year":"2011","unstructured":"Lin J, Haffner MC, Zhang Y, et al. Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate. 2011;71(4):333\u201343.","journal-title":"Prostate"},{"issue":"4","key":"1589_CR90","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ijc.10972","volume":"104","author":"W Wang","year":"2003","unstructured":"Wang W, McLeod HL, Cassidy J. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer. 2003;104(4):504\u201311.","journal-title":"Int J Cancer"},{"key":"1589_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108727","volume":"113","author":"Z Yang","year":"2019","unstructured":"Yang Z, Guo F, Albers AE, Sehouli J, Kaufmann AM. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines. Biomed Pharmacother. 2019;113: 108727.","journal-title":"Biomed Pharmacother"},{"issue":"38","key":"1589_CR92","doi-asserted-by":"publisher","first-page":"40907","DOI":"10.18632\/oncotarget.5723","volume":"6","author":"D Han","year":"2015","unstructured":"Han D, Wu G, Chang C, et al. Disulfiram inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-\u03baB\/Snail pathway. Oncotarget. 2015;6(38):40907\u201319.","journal-title":"Oncotarget"},{"issue":"6","key":"1589_CR93","doi-asserted-by":"publisher","first-page":"300060520925996","DOI":"10.1177\/0300060520925996","volume":"48","author":"J Zhang","year":"2020","unstructured":"Zhang J, Pu K, Bai S, et al. The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-\u03baB pathways. J Int Med Res. 2020;48(6):300060520925996.","journal-title":"J Int Med Res"},{"issue":"3","key":"1589_CR94","first-page":"197","volume":"1","author":"D Cen","year":"2002","unstructured":"Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther. 2002;1(3):197\u2013204.","journal-title":"Mol Cancer Ther"},{"key":"1589_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115642","volume":"426","author":"E Read","year":"2021","unstructured":"Read E, Milford J, Zhu J, Wu L, Bilodeau M, Yang G. The interaction of disulfiram and H2S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth. Toxicol Appl Pharmacol. 2021;426: 115642.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"1589_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051470","volume":"7","author":"K Ketola","year":"2012","unstructured":"Ketola K, Kallioniemi O, Iljin K. Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells. PLoS ONE. 2012;7(12): e51470.","journal-title":"PLoS ONE"},{"issue":"1","key":"1589_CR97","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41467-020-14338-5","volume":"11","author":"Y Terashima","year":"2020","unstructured":"Terashima Y, Toda E, Itakura M, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11(1):609.","journal-title":"Nat Commun"},{"issue":"10","key":"1589_CR98","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.18632\/oncotarget.604","volume":"3","author":"J Triscott","year":"2012","unstructured":"Triscott J, Lee C, Hu K, et al. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide. Oncotarget. 2012;3(10):1112\u201323.","journal-title":"Oncotarget"},{"key":"1589_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.734853","volume":"11","author":"X Zheng","year":"2021","unstructured":"Zheng X, Liu Z, Mi M, Wen Q, Wu G, Zhang L. Disulfiram improves the anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer. Front Oncol. 2021;11: 734853.","journal-title":"Front Oncol"},{"key":"1589_CR100","doi-asserted-by":"publisher","first-page":"1154073","DOI":"10.3389\/fonc.2023.1154073","volume":"13","author":"B Tang","year":"2023","unstructured":"Tang B, Wu M, Zhang L, et al. Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer. Front Oncol. 2023;13:1154073.","journal-title":"Front Oncol"},{"issue":"9","key":"1589_CR101","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/aps.2013.52","volume":"34","author":"HJ Park","year":"2013","unstructured":"Park HJ, Kim MS, Cho K, Yun JH, Choi YJ, Cho CH. Disulfiram deregulates HIF-\u03b1 subunits and blunts tumor adaptation to hypoxia in hepatoma cells. Acta Pharmacol Sin. 2013;34(9):1208\u201316.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"1589_CR102","first-page":"2055","volume":"13","author":"S Huang","year":"2023","unstructured":"Huang S, Xie P, Huang X, et al. Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression. Am J Cancer Res. 2023;13(5):2055\u201365.","journal-title":"Am J Cancer Res"},{"key":"1589_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110771","volume":"109","author":"P Zheng","year":"2023","unstructured":"Zheng P, Wu Y, Wang Y, Hu F. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A\/NDRG1 pathway. Cell Signal. 2023;109: 110771.","journal-title":"Cell Signal"},{"issue":"9","key":"1589_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291981","volume":"18","author":"Z Lafi","year":"2023","unstructured":"Lafi Z, Alshaer W, Gharaibeh L, et al. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS ONE. 2023;18(9): e0291981.","journal-title":"PLoS ONE"},{"key":"1589_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115498","volume":"211","author":"XX Yuan","year":"2023","unstructured":"Yuan XX, Duan YF, Luo C, et al. Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3. Biochem Pharmacol. 2023;211: 115498.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1589_CR106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ijmm.2023.5343","volume":"53","author":"P Li","year":"2024","unstructured":"Li P, Sun Q, Bai S, Wang H, Zhao L. Combination of the cuproptosis inducer disulfiram and anti PD L1 abolishes NSCLC resistance by ATP7B to regulate the HIF 1 signaling pathway. Int J Mol Med. 2024;53(2):19.","journal-title":"Int J Mol Med"},{"issue":"7684","key":"1589_CR107","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, Mistrik M, Andersen KK, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194\u20139.","journal-title":"Nature"},{"issue":"10","key":"1589_CR108","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/bjc.2011.126","volume":"104","author":"NC Yip","year":"2011","unstructured":"Yip NC, Fombon IS, Liu P, et al. Disulfiram modulated ROS-MAPK and NF\u03baB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer. 2011;104(10):1564\u201374.","journal-title":"Br J Cancer"},{"issue":"9","key":"1589_CR109","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2012.442","volume":"107","author":"P Liu","year":"2012","unstructured":"Liu P, Brown S, Goktug T, et al. Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br J Cancer. 2012;107(9):1488\u201397.","journal-title":"Br J Cancer"},{"issue":"7","key":"1589_CR110","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/bjc.2013.534","volume":"109","author":"P Liu","year":"2013","unstructured":"Liu P, Kumar IS, Brown S, et al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Br J Cancer. 2013;109(7):1876\u201385.","journal-title":"Br J Cancer"},{"issue":"1","key":"1589_CR111","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","volume":"290","author":"X Guo","year":"2010","unstructured":"Guo X, Xu B, Pandey S, et al. Disulfiram\/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett. 2010;290(1):104\u201313.","journal-title":"Cancer Lett"},{"issue":"21","key":"1589_CR112","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen D, Cui QC, Yang H, Dou QP. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006;66(21):10425\u201333.","journal-title":"Cancer Res"},{"issue":"10","key":"1589_CR113","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1158\/0008-5472.CAN-09-3752","volume":"70","author":"H Zhang","year":"2010","unstructured":"Zhang H, Chen D, Ringler J, et al. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010;70(10):3996\u20134004.","journal-title":"Cancer Res"},{"issue":"9","key":"1589_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203069","volume":"13","author":"YM Park","year":"2018","unstructured":"Park YM, Go YY, Shin SH, Cho JG, Woo JS, Song JJ. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death. PLoS ONE. 2018;13(9): e0203069.","journal-title":"PLoS ONE"},{"issue":"4","key":"1589_CR115","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.bbrc.2017.03.164","volume":"486","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Kim JY, Lee N, et al. Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells. Biochem Biophys Res Commun. 2017;486(4):1069\u201376.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1589_CR116","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.05.026","volume":"379","author":"JY Kim","year":"2016","unstructured":"Kim JY, Cho Y, Oh E, et al. Disulfiram targets cancer stem-like properties and the HER2\/Akt signaling pathway in HER2-positive breast cancer. Cancer Lett. 2016;379(1):39\u201348.","journal-title":"Cancer Lett"},{"key":"1589_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.752825","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Qian Y, Wei J, et al. The disulfiram\/copper complex induces autophagic cell death in colorectal cancer by targeting ULK1. Front Pharmacol. 2021;12: 752825.","journal-title":"Front Pharmacol"},{"key":"1589_CR118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2017.08.028","volume":"409","author":"J Cong","year":"2017","unstructured":"Cong J, Wang Y, Zhang X, et al. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. Cancer Lett. 2017;409:9\u201319.","journal-title":"Cancer Lett"},{"key":"1589_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.02.039","volume":"827","author":"X Wu","year":"2018","unstructured":"Wu X, Xue X, Wang L, et al. Suppressing autophagy enhances disulfiram\/copper-induced apoptosis in non-small cell lung cancer. Eur J Pharmacol. 2018;827:1\u201312.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1589_CR120","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbrc.2019.03.192","volume":"513","author":"SY You","year":"2019","unstructured":"You SY, Rui W, Chen ST, et al. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate. Biochem Biophys Res Commun. 2019;513(4):891\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1589_CR121","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ijc.27482","volume":"131","author":"C Conticello","year":"2012","unstructured":"Conticello C, Martinetti D, Adamo L, et al. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies. Int J Cancer. 2012;131(9):2197\u2013203.","journal-title":"Int J Cancer"},{"key":"1589_CR122","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1479-5876-12-163","volume":"12","author":"J Zha","year":"2014","unstructured":"Zha J, Chen F, Dong H, et al. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition. J Transl Med. 2014;12:163.","journal-title":"J Transl Med"},{"key":"1589_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114267","volume":"182","author":"K Zuhra","year":"2020","unstructured":"Zuhra K, Panagaki T, Randi EB, et al. Mechanism of cystathionine-\u03b2-synthase inhibition by disulfiram: the role of bis(N, N-diethyldithiocarbamate)-copper(II). Biochem Pharmacol. 2020;182: 114267.","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"1589_CR124","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-15-1798","volume":"22","author":"X Lun","year":"2016","unstructured":"Lun X, Wells JC, Grinshtein N, et al. Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma. Clin Cancer Res. 2016;22(15):3860\u201375.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1589_CR125","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.taap.2008.01.022","volume":"229","author":"L Li","year":"2008","unstructured":"Li L, Yang H, Chen D, Cui C, Dou QP. Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells. Toxicol Appl Pharmacol. 2008;229(2):206\u201314.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1589_CR126","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2016.11.022","volume":"386","author":"JY Kim","year":"2017","unstructured":"Kim JY, Lee N, Kim YJ, et al. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation. Cancer Lett. 2017;386:151\u201360.","journal-title":"Cancer Lett"},{"issue":"11","key":"1589_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251957","volume":"16","author":"R Serra","year":"2021","unstructured":"Serra R, Zhao T, Huq S, et al. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model. PLoS ONE. 2021;16(11): e0251957.","journal-title":"PLoS ONE"},{"key":"1589_CR128","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2021.02.002","volume":"505","author":"K Wang","year":"2021","unstructured":"Wang K, Michelakos T, Wang B, et al. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Lett. 2021;505:37\u201348.","journal-title":"Cancer Lett"},{"issue":"1","key":"1589_CR129","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12885-022-09574-5","volume":"22","author":"HZ Cao","year":"2022","unstructured":"Cao HZ, Yang WT, Zheng PS. Cytotoxic effect of disulfiram\/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells. BMC Cancer. 2022;22(1):521.","journal-title":"BMC Cancer"},{"issue":"21","key":"1589_CR130","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.3390\/ijms232113276","volume":"23","author":"YL Ni","year":"2022","unstructured":"Ni YL, Chien PJ, Hsieh HC, et al. Disulfiram\/copper suppresses cancer stem cell activity in differentiated thyroid cancer cells by inhibiting BMI1 expression. Int J Mol Sci. 2022;23(21):13276.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1589_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.18632\/oncoscience.5","volume":"1","author":"M Papaioannou","year":"2013","unstructured":"Papaioannou M, Mylonas I, Kast RE, Br\u00fcning A. Disulfiram\/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition. Oncoscience. 2013;1(1):21\u20139.","journal-title":"Oncoscience"},{"issue":"2","key":"1589_CR132","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000353915","volume":"59","author":"J Navr\u00e1tilov\u00e1","year":"2013","unstructured":"Navr\u00e1tilov\u00e1 J, Hankeov\u00e1 T, Bene\u0161 P, \u0160marda J. Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram\/Cu2+ complex to breast and colon cancer cells. Chemotherapy. 2013;59(2):112\u201320.","journal-title":"Chemotherapy"},{"issue":"19","key":"1589_CR133","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.3390\/cancers14194715","volume":"14","author":"X Gao","year":"2022","unstructured":"Gao X, Huang H, Pan C, et al. Disulfiram\/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma. Cancers (Basel). 2022;14(19):4715.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1589_CR134","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.3390\/ijms24043418","volume":"24","author":"J Xie","year":"2023","unstructured":"Xie J, Liu J, Zhao M, et al. Disulfiram\/Cu kills and sensitizes BRAF-mutant thyroid cancer cells to BRAF kinase inhibitor by ROS-dependently relieving feedback activation of MAPK\/ERK and PI3K\/AKT pathways. Int J Mol Sci. 2023;24(4):3418.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1589_CR135","first-page":"2442","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, Guo L, Zhang B, et al. Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. Am J Cancer Res. 2019;9(11):2442\u201355.","journal-title":"Am J Cancer Res"},{"key":"1589_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102122","volume":"46","author":"X Ren","year":"2021","unstructured":"Ren X, Li Y, Zhou Y, et al. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis. Redox Biol. 2021;46: 102122.","journal-title":"Redox Biol"},{"issue":"4","key":"1589_CR137","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/carcin\/bgad020","volume":"44","author":"AJ Bagherpoor","year":"2023","unstructured":"Bagherpoor AJ, Shameem M, Luo X, Seelig D, Kassie F. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram\u2013copper (DSF\u2013Cu) in cell line models and mice. Carcinogenesis. 2023;44(4):291\u2013303.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1589_CR138","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-017-0493-5","volume":"36","author":"R Bista","year":"2017","unstructured":"Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E. Disulfiram overcomes bortezomib and cytarabine resistance in down-syndrome-associated acute myeloid leukemia cells. J Exp Clin Cancer Res. 2017;36(1):22.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1589_CR139","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/1535-7163.MCT-23-0876","volume":"23","author":"L Song","year":"2024","unstructured":"Song L, Nguyen V, Xie J, et al. ATPase copper transporting beta (ATP7B) Is a novel target for improving the therapeutic efficacy of docetaxel by disulfiram\/copper in human prostate cancer. Mol Cancer Ther. 2024;23(6):854\u201363.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"1589_CR140","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1021\/cb400198p","volume":"8","author":"MA Cater","year":"2013","unstructured":"Cater MA, Pearson HB, Wolyniec K, et al. Increasing intracellular bioavailable copper selectively targets prostate cancer cells. ACS Chem Biol. 2013;8(7):1621\u201331.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"1589_CR141","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/BJ20110123","volume":"436","author":"MA Cater","year":"2011","unstructured":"Cater MA, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011;436(2):481\u201391.","journal-title":"Biochem J"},{"issue":"Pt 2","key":"1589_CR142","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.freeradbiomed.2022.11.023","volume":"193","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liang S, Geng H, et al. Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore. Free Radic Biol Med. 2022;193(Pt 2):638\u201347.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1589_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2015.11.005","volume":"23","author":"W Zhang","year":"2016","unstructured":"Zhang W, Chen C, Shi H, et al. Curcumin is a biologically active copper chelator with antitumor activity. Phytomedicine. 2016;23(1):1\u20138.","journal-title":"Phytomedicine"},{"key":"1589_CR144","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.freeradbiomed.2018.09.017","volume":"129","author":"Y Ji","year":"2018","unstructured":"Ji Y, Dai F, Zhou B. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells. Free Radic Biol Med. 2018;129:215\u201326.","journal-title":"Free Radic Biol Med"},{"key":"1589_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13543784.2021.1840550","volume":"30","author":"VM Gohil","year":"2021","unstructured":"Gohil VM. Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders. Expert Opin Investig Drugs. 2021;30:1\u20134.","journal-title":"Expert Opin Investig Drugs"},{"key":"1589_CR146","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.aaz8899","volume":"368","author":"LM Guthrie","year":"2020","unstructured":"Guthrie LM, Soma S, Yuan S, Silva A, Zulkifli M, Snavely TC, et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science. 2020;368:620\u20135.","journal-title":"Science"},{"key":"1589_CR147","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216722120","volume":"120","author":"M Zulkifli","year":"2023","unstructured":"Zulkifli M, Spelbring AN, Zhang Y, et al. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. Proc Natl Acad Sci USA. 2023;120: e2216722120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1589_CR148","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41:271.","journal-title":"J Exp Clin Cancer Res"},{"key":"1589_CR149","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","volume":"31","author":"SJ O'Day","year":"2013","unstructured":"O\u2019Day SJ, Eggermont AM, Chiarion-Sileni V, Kefford R, Grob JJ, Mortier L, et al. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol. 2013;31:1211\u20138.","journal-title":"J Clin Oncol"},{"key":"1589_CR150","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. Semin Cancer Biol. 2022;87:184\u201395.","journal-title":"Semin Cancer Biol"},{"key":"1589_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","volume":"87","author":"C Lu","year":"2021","unstructured":"Lu C, Li X, Ren Y, Zhang X. Disulfiram: a novel repurposed drug for cancer therapy. Cancer Chemother Pharmacol. 2021;87:159\u201372.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1589_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216157","volume":"561","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou M, Liu Y, Si Z. Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies. Cancer Lett. 2023;561: 216157.","journal-title":"Cancer Lett"},{"issue":"3","key":"1589_CR153","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.4149","volume":"6","author":"K Werlenius","year":"2023","unstructured":"Werlenius K, Kinhult S, Solheim TS, et al. Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: a randomized clinical trial. JAMA Netw Open. 2023;6(3): e234149.","journal-title":"JAMA Netw Open"},{"issue":"14","key":"1589_CR154","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/pros.23022","volume":"75","author":"D Denoyer","year":"2015","unstructured":"Denoyer D, Clatworthy SA, Masaldan S, Meggyesy PM, Cater MA. Heterogeneous copper concentrations in cancerous human prostate tissues. Prostate. 2015;75(14):1510\u20137.","journal-title":"Prostate"},{"key":"1589_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2008.08.015","volume":"182","author":"X Mao","year":"2008","unstructured":"Mao X, Schimmer AD. The toxicology of clioquinol. Toxicol Lett. 2008;182:1\u20136.","journal-title":"Toxicol Lett"},{"key":"1589_CR156","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biomedicines9091086","volume":"9","author":"V Zoi","year":"2021","unstructured":"Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA. The role of curcumin in cancer treatment. Biomedicines. 2021;9:1086.","journal-title":"Biomedicines"},{"issue":"2","key":"1589_CR157","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jpba.2010.09.007","volume":"54","author":"L Wu","year":"2011","unstructured":"Wu L, Zhou L, Liu DQ, Vogt FG, Kord AS. LC-MS\/MS and density functional theory study of copper(II) and nickel(II) chelating complexes of elesclomol (a novel anticancer agent). J Pharm Biomed Anal. 2011;54(2):331\u20136.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"1589_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102139","volume":"298","author":"NM Garza","year":"2022","unstructured":"Garza NM, Zulkifli M, Gohil VM. Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery. J Biol Chem. 2022;298(7): 102139.","journal-title":"J Biol Chem"},{"issue":"8","key":"1589_CR159","doi-asserted-by":"publisher","first-page":"186","DOI":"10.31083\/j.fbl2808186","volume":"28","author":"M Chu","year":"2023","unstructured":"Chu M, An X, Fu C, et al. Disulfiram\/copper induce ferroptosis in triple-negative breast cancer cell line MDA-MB-231. Front Biosci (Landmark Ed). 2023;28(8):186.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"11","key":"1589_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108218","volume":"26","author":"X Yang","year":"2023","unstructured":"Yang X, Deng L, Diao X, et al. Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer. iScience. 2023;26(11): 108218.","journal-title":"iScience"},{"key":"1589_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159: 114301.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"1589_CR162","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/jca.77445","volume":"13","author":"X Nie","year":"2022","unstructured":"Nie X, Chen H, Xiong Y, Chen J, Liu T. Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1\/lipoic acid pathway activation. J Cancer. 2022;13(14):3503\u201314.","journal-title":"J Cancer"},{"key":"1589_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116727","volume":"175","author":"Y Gao","year":"2024","unstructured":"Gao Y, Jin F, Zhang P, et al. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes. Biomed Pharmacother. 2024;175: 116727.","journal-title":"Biomed Pharmacother"},{"issue":"43","key":"1589_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204733","volume":"34","author":"Y Xu","year":"2022","unstructured":"Xu Y, Liu SY, Zeng L, et al. An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy. Adv Mater. 2022;34(43): e2204733.","journal-title":"Adv Mater"},{"key":"1589_CR165","doi-asserted-by":"publisher","first-page":"2300941","DOI":"10.1002\/adfm.202300941","volume":"33","author":"F Zhao","year":"2023","unstructured":"Zhao F, Liang L, Wang H, et al. H2S-activated ion-interference therapy: a novel tumor targeted therapy based on copper-overload-mediated cuproptosis and pyroptosis. Adv Funct Mater. 2023;33:2300941.","journal-title":"Adv Funct Mater"},{"key":"1589_CR166","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1021\/jacs.9b03503","volume":"141","author":"W Wu","year":"2019","unstructured":"Wu W, Yu L, Jiang Q, Huo M, Lin H, Wang L, et al. Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. J Am Chem Soc. 2019;141:11531\u20139.","journal-title":"J Am Chem Soc"},{"key":"1589_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202205354","volume":"19","author":"W Jia","year":"2023","unstructured":"Jia W, Tian H, Jiang J, et al. Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma. Small. 2023;19: e2205354.","journal-title":"Small"},{"key":"1589_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202301346","volume":"12","author":"F Zhao","year":"2023","unstructured":"Zhao F, Yu H, Liang L, et al. Redox homeostasis disruptors based on metal-phenolic network nanoparticles for chemo\/chemodynamic synergistic tumor therapy through activating apoptosis and cuproptosis. Adv Healthc Mater. 2023;12: e2301346.","journal-title":"Adv Healthc Mater"},{"key":"1589_CR169","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202213922","volume":"62","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yu Q, Song J, et al. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy. Angew Chem Int Ed Engl. 2023;62: e202213922.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1589_CR170","doi-asserted-by":"publisher","first-page":"2302054","DOI":"10.1002\/adfm.202302054","volume":"33","author":"L Chan","year":"2023","unstructured":"Chan L, Liu Y, Chen M, et al. Cuproptosis-driven enhancement of thermotherapy by sequentially response Cu2\u2212xSe via copper chemical transition. Adv Funct Mater. 2023;33:2302054.","journal-title":"Adv Funct Mater"},{"key":"1589_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35: e2212267.","journal-title":"Adv Mater"},{"key":"1589_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202949","volume":"12","author":"W Xu","year":"2023","unstructured":"Xu W, Wang Y, Hou G, et al. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy. Adv Healthc Mater. 2023;12: e2202949.","journal-title":"Adv Healthc Mater"},{"key":"1589_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202306584","volume":"33","author":"H Tian","year":"2023","unstructured":"Tian H, Duan J, Li B, et al. Clinical chemotherapeutic agent coordinated copper-based nanoadjuvants for efficiently sensitizing cancer chemo-immunotherapy by cuproptosis-mediated mitochondrial metabolic reprogramming. Adv Funct Mater. 2023;33: 2306584. https:\/\/doi.org\/10.1002\/adfm.202306584.","journal-title":"Adv Funct Mater"},{"key":"1589_CR174","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mattod.2023.06.024","volume":"68","author":"XK Jin","year":"2023","unstructured":"Jin XK, Liang JL, Zhang SM, et al. Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti-tumor immunity in colorectal cancer. Mater Today. 2023;68:108\u201324.","journal-title":"Mater Today"},{"key":"1589_CR175","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1039\/D2TB01150F","volume":"10","author":"Y Lu","year":"2022","unstructured":"Lu Y, Pan Q, Gao W, Pu Y, He B. Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis. J Mater Chem B. 2022;10:6296\u2013306.","journal-title":"J Mater Chem B"},{"key":"1589_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101911","volume":"51","author":"QX Huang","year":"2023","unstructured":"Huang QX, Liang JL, Chen QW, et al. Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 2023;51: 101911.","journal-title":"Nano Today"},{"key":"1589_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300167","volume":"12","author":"J Zhang","year":"2023","unstructured":"Zhang J, Peng L, Hao Y, Yang H, Zhao W, Mao C. Biodegradable CuMoO4 nanodots with multienzyme activities for multimodal treatment of tumor. Adv Healthc Mater. 2023;12: e2300167.","journal-title":"Adv Healthc Mater"},{"key":"1589_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123025","volume":"640","author":"J Zhang","year":"2023","unstructured":"Zhang J, Han M, Zhang J, et al. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism. Int J Pharm. 2023;640: 123025.","journal-title":"Int J Pharm"},{"key":"1589_CR179","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1021\/acs.nanolett.3c00434","volume":"23","author":"K Chen","year":"2023","unstructured":"Chen K, Zhou A, Zhou X, Liu Y, Xu Y, Ning X. An intelligent cell-derived nanorobot bridges synergistic crosstalk between sonodynamic therapy and cuproptosis to promote cancer treatment. Nano Lett. 2023;23:3038\u201347.","journal-title":"Nano Lett"},{"key":"1589_CR180","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcis.2023.03.065","volume":"641","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zhao Z, Cheng H, Shen Y, Xie A, Zhu M. In-situ fabrication of novel Au nanoclusters-Cu2+@sodium alginate\/hyaluronic acid nanohybrid gels for cuproptosis enhanced photothermal\/photodynamic\/chemodynamic therapy via tumor microenvironment regulation. J Colloid Interface Sci. 2023;641:215\u201328.","journal-title":"J Colloid Interface Sci"},{"key":"1589_CR181","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","volume":"362","author":"T Liu","year":"2023","unstructured":"Liu T, Zhou Z, Zhang M, et al. Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor. J Control Release. 2023;362:502\u201312.","journal-title":"J Control Release"},{"key":"1589_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.145795","volume":"474","author":"J Zhong","year":"2023","unstructured":"Zhong J, Zheng X, Wen Y, Wang SB, Zhan G, Chen AZ. In situ sacrificial growth of metastable copper-enriched nanomedicine for cuproptosis-based synergistic cancer therapy. Chem Eng J. 2023;474: 145795.","journal-title":"Chem Eng J"},{"key":"1589_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202400496","volume":"34","author":"G Zhu","year":"2024","unstructured":"Zhu G, Wang M, Qiao L, et al. Lysosomal rupture-mediated \u201cbroken window effect\u201d to amplify cuproptosis and pyroptosis for high-efficiency cancer immunotherapy. Adv Funct Mater. 2024;34: 2400496. https:\/\/doi.org\/10.1002\/adfm.202400496.","journal-title":"Adv Funct Mater"},{"key":"1589_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122512","volume":"307","author":"X Yu","year":"2024","unstructured":"Yu X, Li B, Yan J, et al. Cuproptotic nanoinducer-driven proteotoxic stress potentiates cancer immunotherapy by activating the mtDNA-cGAS-STING signaling. Biomaterials. 2024;307: 122512.","journal-title":"Biomaterials"},{"issue":"6","key":"1589_CR185","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1021\/jacs.3c08622","volume":"146","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Zhao H, et al. Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity. J Am Chem Soc. 2024;146(6):3675\u201388.","journal-title":"J Am Chem Soc"},{"issue":"5","key":"1589_CR186","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.apsb.2024.01.017","volume":"14","author":"C Yan","year":"2024","unstructured":"Yan C, Liu Y, Zhao G, et al. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy. Acta Pharm Sin B. 2024;14(5):2281\u201397.","journal-title":"Acta Pharm Sin B"},{"key":"1589_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102196","volume":"55","author":"J Zhu","year":"2024","unstructured":"Zhu J, You Y, Zhang W, et al. Sensitizing cuproptosis by endogenous copper-triggered bioorthogonal nanoremodeler. Nano Today. 2024;55: 102196.","journal-title":"Nano Today"},{"key":"1589_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202308565","author":"J Chang","year":"2024","unstructured":"Chang J, Yin W, Zhi H, et al. Copper deposition in polydopamine nanostructure to promote cuproptosis by catalytically inhibiting copper exporters of tumor cells for cancer immunotherapy. Small. 2024. https:\/\/doi.org\/10.1002\/smll.202308565.","journal-title":"Small"},{"issue":"15","key":"1589_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306031","volume":"11","author":"C Du","year":"2024","unstructured":"Du C, Guo X, Qiu X, et al. Self-reinforced bimetallic mito-jammer for Ca2+ overload-mediated cascade mitochondrial damage for cancer cuproptosis sensitization. Adv Sci (Weinh). 2024;11(15): e2306031.","journal-title":"Adv Sci (Weinh)"},{"key":"1589_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100996","volume":"25","author":"L Ye","year":"2024","unstructured":"Ye L, Yu C, Xia J, et al. Multifunctional nanomaterials via cell cuproptosis and oxidative stress for treating osteosarcoma and OS-induced bone destruction. Mater Today Bio. 2024;25: 100996.","journal-title":"Mater Today Bio"},{"issue":"18","key":"1589_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202402397","volume":"63","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Liu B, et al. Glutathione induced in situ synthesis of Cu single-atom nanozymes with anaerobic glycolysis metabolism interference for boosting cuproptosis. Angew Chem Int Ed Engl. 2024;63(18): e202402397.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1589_CR192","first-page":"0335","volume":"7","author":"C Xiao","year":"2024","unstructured":"Xiao C, Li J, Hua A, et al. Hyperbaric oxygen boosts antitumor efficacy of copper-diethyldithiocarbamate nanoparticles against pancreatic ductal adenocarcinoma by regulating cancer stem cell metabolism. Research (Wash D C). 2024;7:0335.","journal-title":"Research (Wash D C)"},{"key":"1589_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.148522","volume":"481","author":"X He","year":"2024","unstructured":"He X, Li M, Fan S, et al. Copper peroxide and cisplatin co-loaded silica nanoparticles-based trinity strategy for cooperative cuproptosis\/chemo\/chemodynamic cancer therapy. Chem Eng J. 2024;481: 148522.","journal-title":"Chem Eng J"},{"key":"1589_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.484","volume":"5","author":"P Pei","year":"2024","unstructured":"Pei P, Wang Y, Shen W, et al. Oxygen-driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy. Aggregate. 2024;5: e484. https:\/\/doi.org\/10.1002\/agt2.484.","journal-title":"Aggregate"},{"key":"1589_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122455","volume":"305","author":"Y Dai","year":"2024","unstructured":"Dai Y, Zhu L, Li X, et al. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence\/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy. Biomaterials. 2024;305: 122455.","journal-title":"Biomaterials"},{"issue":"18","key":"1589_CR196","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309984","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu X, Chen X, Lin C, et al. Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv Sci (Weinh). 2024;11(18): e2309984.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"1589_CR197","doi-asserted-by":"publisher","first-page":"2312795","DOI":"10.1002\/adfm.202312795","volume":"34","author":"C Hao","year":"2024","unstructured":"Hao C, Huang L, Zhang H, et al. Chiral CuxOS@ Fe-MOFs for enhanced cancer therapy. Adv Func Mater. 2024;34(10):2312795.","journal-title":"Adv Func Mater"},{"issue":"23","key":"1589_CR198","doi-asserted-by":"publisher","first-page":"23998","DOI":"10.1021\/acsnano.3c08875","volume":"17","author":"W Shen","year":"2023","unstructured":"Shen W, Pei P, Zhang C, et al. A polymeric hydrogel to eliminate programmed death-ligand 1 for enhanced tumor radio-immunotherapy. ACS Nano. 2023;17(23):23998\u20134011.","journal-title":"ACS Nano"},{"issue":"21","key":"1589_CR199","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1021\/acsnano.3c04903","volume":"17","author":"J Xia","year":"2023","unstructured":"Xia J, Hu C, Ji Y, et al. Copper-loaded nanoheterojunction enables superb orthotopic osteosarcoma therapy via oxidative stress and cell cuproptosis. ACS Nano. 2023;17(21):21134\u201352.","journal-title":"ACS Nano"},{"issue":"10","key":"1589_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304407","volume":"20","author":"J Zheng","year":"2024","unstructured":"Zheng J, Ge H, Guo M, et al. Photoinduced cuproptosis with tumor-specific for metastasis-inhibited cancer therapy. Small. 2024;20(10): e2304407.","journal-title":"Small"},{"issue":"8","key":"1589_CR201","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308241","volume":"36","author":"L Qiao","year":"2024","unstructured":"Qiao L, Zhu G, Jiang T, et al. Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv Mater. 2024;36(8): e2308241.","journal-title":"Adv Mater"},{"issue":"33","key":"1589_CR202","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303694","volume":"10","author":"W Chen","year":"2023","unstructured":"Chen W, Xie W, Gao Z, et al. Mild-photothermal effect induced high efficiency ferroptosis-boosted-cuproptosis based on Cu2O@Mn3Cu3O8 nanozyme. Adv Sci (Weinh). 2023;10(33): e2303694.","journal-title":"Adv Sci (Weinh)"},{"key":"1589_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2023.112568","volume":"237","author":"P Hu","year":"2024","unstructured":"Hu P, Li Y, Zhang L, et al. Defect-engineered photothermal nanozyme with NIR-II absorption induces cuproptosis\u2013apoptosis for synergized cancer immunotherapy and fast wound healing. Mater Des. 2024;237: 112568.","journal-title":"Mater Des"},{"issue":"17","key":"1589_CR204","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202309215","volume":"20","author":"S Lu","year":"2024","unstructured":"Lu S, Tian H, Li B, et al. An ellagic acid coordinated copper-based nanoplatform for efficiently overcoming cancer chemoresistance by cuproptosis and synergistic inhibition of cancer cell stemness. Small. 2024;20(17): e2309215.","journal-title":"Small"},{"issue":"4","key":"1589_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302537","volume":"13","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Zhuang H, Zeng X, et al. Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy. Adv Healthc Mater. 2024;13(4): e2302537.","journal-title":"Adv Healthc Mater"},{"issue":"44","key":"1589_CR206","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202311549","volume":"62","author":"H Ding","year":"2023","unstructured":"Ding H, Ren F, Liu P, et al. Cu2+-anchored carbon nano-photocatalysts for visible water splitting to boost hydrogen cuproptosis. Angew Chem Int Ed Engl. 2023;62(44): e202311549.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"Pt A","key":"1589_CR207","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jcis.2023.09.042","volume":"653","author":"Y Xia","year":"2024","unstructured":"Xia Y, Gu M, Wang J, et al. Tumor microenvironment-activated, immunomodulatory nanosheets loaded with copper(II) and 5-FU for synergistic chemodynamic therapy and chemotherapy. J Colloid Interface Sci. 2024;653(Pt A):137\u201347.","journal-title":"J Colloid Interface Sci"},{"key":"1589_CR208","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.actbio.2023.12.022","volume":"175","author":"W Liang","year":"2024","unstructured":"Liang W, Han C, Zhang D, et al. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy. Acta Biomater. 2024;175:341\u201352.","journal-title":"Acta Biomater"},{"key":"1589_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102223","volume":"56","author":"W Li","year":"2024","unstructured":"Li W, Xiao Y, Guo G, et al. Cuprous oxide nanocomposites with photothermal (PTT) and chemical dynamics (CDT) effects induce cuproptosis in breast cancer using the strategy of increasing inflow and reducing outflow. Nano Today. 2024;56: 102223.","journal-title":"Nano Today"},{"key":"1589_CR210","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304522","volume":"13","author":"J Deng","year":"2024","unstructured":"Deng J, Zhuang H, Shao S, et al. Mitochondrial-targeted copper delivery for cuproptosis-based synergistic cancer therapy. Adv Healthc Mater. 2024;13: 2304522. https:\/\/doi.org\/10.1002\/adhm.202304522.","journal-title":"Adv Healthc Mater"},{"issue":"15","key":"1589_CR211","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3201","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X. Cellular Trojan Horse initiates bimetallic Fe\u2013Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Sci Adv. 2024;10(15): eadk3201.","journal-title":"Sci Adv"},{"key":"1589_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401047","volume":"11","author":"H Wu","year":"2024","unstructured":"Wu H, Zhang Z, Cao Y, et al. A self-amplifying ROS-responsive nanoplatform for simultaneous cuproptosis and cancer immunotherapy. Adv Sci (Weinh). 2024;11: 2401047. https:\/\/doi.org\/10.1002\/advs.202401047.","journal-title":"Adv Sci (Weinh)"},{"key":"1589_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.04.028","author":"C Yan","year":"2024","unstructured":"Yan C, Lv H, Feng Y, et al. Inhalable nanoparticles with enhanced cuproptosis and cGAS\u2013STING activation for synergistic lung metastasis immunotherapy. Acta Pharm Sin B. 2024. https:\/\/doi.org\/10.1016\/j.apsb.2024.04.028.","journal-title":"Acta Pharm Sin B"},{"key":"1589_CR214","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/IJN.S455355","volume":"19","author":"W Xie","year":"2024","unstructured":"Xie W, Zhang Y, Xu Q, et al. A unique approach: biomimetic graphdiyne-based nanoplatform to treat prostate cancer by combining cuproptosis and enhanced chemodynamic therapy. Int J Nanomed. 2024;19:3957\u201372.","journal-title":"Int J Nanomed"},{"key":"1589_CR215","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202402022","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhu J, Wang S, et al. A copper\/ferrous-engineering redox homeostasis disruptor for cuproptosis\/ferroptosis co-activated nanocatalytic therapy in liver cancer. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202402022.","journal-title":"Adv Funct Mater"},{"key":"1589_CR216","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jconrel.2024.05.045","volume":"371","author":"N Zhang","year":"2024","unstructured":"Zhang N, Ping W, Rao K, et al. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy. J Control Release. 2024;371:204\u201315.","journal-title":"J Control Release"},{"issue":"11","key":"1589_CR217","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.3390\/cells10113197","volume":"10","author":"C Huang","year":"2021","unstructured":"Huang C, Radi RH, Arbiser JL. Mitochondrial metabolism in melanoma. Cells. 2021;10(11):3197.","journal-title":"Cells"},{"issue":"10","key":"1589_CR218","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1080\/10428194.2021.1910685","volume":"62","author":"RJ Stubbins","year":"2021","unstructured":"Stubbins RJ, Maksakova IA, Sanford DS, Rouhi A, Kuchenbauer F. Mitochondrial metabolism: powering new directions in acute myeloid leukemia. Leuk Lymphoma. 2021;62(10):2331\u201341.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"1589_CR219","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","volume":"24","author":"A Luengo","year":"2017","unstructured":"Luengo A, Gui DY, Vander Heiden MG. Targeting metabolism for cancer therapy. Cell Chem Biol. 2017;24(9):1161\u201380.","journal-title":"Cell Chem Biol"},{"key":"1589_CR220","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.03.009","volume":"135","author":"A Cruz-Berm\u00fadez","year":"2019","unstructured":"Cruz-Berm\u00fadez A, Laza-Briviesca R, Vicente-Blanco RJ, et al. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1\u03b1 in NSCLC which can be overcome by OXPHOS inhibition. Free Radic Biol Med. 2019;135:167\u201381.","journal-title":"Free Radic Biol Med"},{"issue":"39","key":"1589_CR221","doi-asserted-by":"publisher","first-page":"41706","DOI":"10.18632\/oncotarget.5991","volume":"6","author":"C Denise","year":"2015","unstructured":"Denise C, Paoli P, Calvani M, et al. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Oncotarget. 2015;6(39):41706\u201321.","journal-title":"Oncotarget"},{"key":"1589_CR222","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"issue":"2","key":"1589_CR223","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41419-024-06489-w","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Chen L, Cong Y, et al. Protein phosphatase 1 regulatory subunit 15 A promotes translation initiation and induces G2M phase arrest during cuproptosis in cancers. Cell Death Dis. 2024;15(2):149.","journal-title":"Cell Death Dis"},{"key":"1589_CR224","doi-asserted-by":"publisher","first-page":"1036408","DOI":"10.3389\/fgene.2022.1036408","volume":"13","author":"K Fan","year":"2023","unstructured":"Fan K, Dong Y, Li T, Li Y. Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma. Front Genet. 2023;13:1036408.","journal-title":"Front Genet"},{"issue":"8","key":"1589_CR225","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395.","journal-title":"Autophagy"},{"issue":"10","key":"1589_CR226","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","volume":"472","author":"J Chen","year":"2020","unstructured":"Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch. 2020;472(10):1415\u201329.","journal-title":"Pflugers Arch"},{"issue":"11","key":"1589_CR227","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou H, Zhai X, et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14(11):733.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1589_CR228","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-024-02972-6","volume":"43","author":"X Wang","year":"2024","unstructured":"Wang X, Shi Y, Shi H, et al. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis. J Exp Clin Cancer Res. 2024;43(1):68.","journal-title":"J Exp Clin Cancer Res"},{"key":"1589_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.996307","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Liu Y, Wang Y, Kang R, Tang D. HMGB1 is a mediator of cuproptosis-related sterile inflammation. Front Cell Dev Biol. 2022;10: 996307.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1589_CR230","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, et al. Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523.","journal-title":"Nat Commun"},{"key":"1589_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.103007","volume":"69","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zhou C, Ren X, et al. Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biol. 2024;69: 103007.","journal-title":"Redox Biol"},{"issue":"11","key":"1589_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101264","volume":"4","author":"T Xing","year":"2023","unstructured":"Xing T, Li L, Chen Y, et al. Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma. Cell Rep Med. 2023;4(11): 101264.","journal-title":"Cell Rep Med"},{"issue":"8","key":"1589_CR233","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3390\/cancers15082286","volume":"15","author":"Z Wu","year":"2023","unstructured":"Wu Z, Lin C, Zhang F, et al. TIGD1 function as a potential cuproptosis regulator following a novel cuproptosis-related gene risk signature in colorectal cancer. Cancers (Basel). 2023;15(8):2286.","journal-title":"Cancers (Basel)"},{"key":"1589_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122081","volume":"332","author":"K Wang","year":"2023","unstructured":"Wang K, Zhang Y, Ao M, Luo H, Mao W, Li B. Multi-omics analysis defines a cuproptosis-related prognostic model for ovarian cancer: implication of WASF2 in cuproptosis resistance. Life Sci. 2023;332: 122081.","journal-title":"Life Sci"},{"issue":"2","key":"1589_CR235","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms24021667","volume":"24","author":"S Huo","year":"2023","unstructured":"Huo S, Wang Q, Shi W, et al. ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. 2023;24(2):1667.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1589_CR236","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300474R","volume":"37","author":"X Wang","year":"2023","unstructured":"Wang X, Jia JH, Zhang M, et al. Adrenomedullin\/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis. FASEB J. 2023;37(10): e23143.","journal-title":"FASEB J"},{"issue":"7\u20138","key":"1589_CR237","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10495-023-01845-1","volume":"28","author":"J Lu","year":"2023","unstructured":"Lu J, Ling X, Sun Y, et al. FDX1 enhances endometriosis cell cuproptosis via G6PD-mediated redox homeostasis. Apoptosis. 2023;28(7\u20138):1128\u201340.","journal-title":"Apoptosis"},{"issue":"2","key":"1589_CR238","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7150\/ijbs.84399","volume":"20","author":"S Tian","year":"2024","unstructured":"Tian S, Wang R, Wang Y, et al. p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization. Int J Biol Sci. 2024;20(2):516\u201336.","journal-title":"Int J Biol Sci"},{"key":"1589_CR239","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.bbamcr.2011.09.013","volume":"1823","author":"RE Carraway","year":"2012","unstructured":"Carraway RE, Dobner PR. Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells. Biochim Biophys Acta. 2012;1823:544\u201357.","journal-title":"Biochim Biophys Acta"},{"key":"1589_CR240","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41419-022-04974-8","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu K, Huang J, Liu J, Klionsky DJ, Kang R, Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022;13:521.","journal-title":"Cell Death Dis"},{"key":"1589_CR241","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/jog.14779","volume":"47","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Bao L, Li M, Chang K, Yi X. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo. J Obstet Gynaecol Res. 2021;47:2481\u201391.","journal-title":"J Obstet Gynaecol Res"},{"key":"1589_CR242","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3389\/fonc.2019.01398","volume":"9","author":"HH Zhou","year":"2019","unstructured":"Zhou HH, Chen X, Cai LY, Nan XW, Chen JH, Chen XX, et al. Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer. Front Oncol. 2019;9:1398.","journal-title":"Front Oncol"},{"key":"1589_CR243","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2: e1054549.","journal-title":"Mol Cell Oncol"},{"key":"1589_CR244","first-page":"323","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Yan H, Xu X, Liu H, Wu C, Zhao L. Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway. Oncol Lett. 2020;19:323\u201333.","journal-title":"Oncol Lett"},{"key":"1589_CR245","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1111\/febs.17135","volume":"291","author":"F Chen","year":"2024","unstructured":"Chen F, Wu S, Kuang N, Zeng Y, Li M, Xu C. ABCB1-mediated docetaxel resistance reversed by erastin in prostate cancer. FEBS J. 2024;291:3249\u201366.","journal-title":"FEBS J"},{"key":"1589_CR246","first-page":"347","volume":"46","author":"AK Holzer","year":"2005","unstructured":"Holzer AK, Samimi G, Naerdemann, et al. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Proc Am Assoc Cancer Res. 2005;46:347.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"1589_CR247","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1158\/1535-7163.1543.3.12","volume":"3","author":"IS Song","year":"2004","unstructured":"Song IS, Savaraj N, Siddik ZH, et al. Roles of copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and resistant cells. Mol Cancer Ther. 2004;3:1543\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1589_CR248","first-page":"1312","volume":"60","author":"M Komatsu","year":"2000","unstructured":"Komatsu M, Sumizawa T, Mutoh M, et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 2000;60(5):1312\u20136.","journal-title":"Cancer Res"},{"issue":"14","key":"1589_CR249","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","volume":"10","author":"G Samimi","year":"2004","unstructured":"Samimi G, Safaei R, Katano K, et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res. 2004;10(14):4661\u20139.","journal-title":"Clin Cancer Res"},{"issue":"30","key":"1589_CR250","doi-asserted-by":"publisher","first-page":"12109","DOI":"10.1021\/jacs.9b05550","volume":"141","author":"A Lasorsa","year":"2019","unstructured":"Lasorsa A, Nardella MI, Rosato A, et al. Mechanistic and structural basis for inhibition of copper trafficking by platinum anticancer drugs. J Am Chem Soc. 2019;141(30):12109\u201320.","journal-title":"J Am Chem Soc"},{"issue":"12","key":"1589_CR251","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41416-019-0609-0","volume":"121","author":"Y Kita","year":"2019","unstructured":"Kita Y, Hamada A, Saito R, et al. Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies. Br J Cancer. 2019;121(12):1027\u201338.","journal-title":"Br J Cancer"},{"issue":"17","key":"1589_CR252","doi-asserted-by":"publisher","first-page":"17428","DOI":"10.1074\/jbc.M401493200","volume":"279","author":"Y Guo","year":"2004","unstructured":"Guo Y, Smith K, Lee J, Thiele DJ, Petris MJ. Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J Biol Chem. 2004;279(17):17428\u201333.","journal-title":"J Biol Chem"},{"issue":"5","key":"1589_CR253","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.biocel.2013.01.018","volume":"45","author":"NK Wee","year":"2013","unstructured":"Wee NK, Weinstein DC, Fraser ST, Assinder SJ. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int J Biochem Cell Biol. 2013;45(5):960\u20133.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1589_CR254","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/biomedicines9040391","volume":"9","author":"N Horn","year":"2021","unstructured":"Horn N, Wittung-Stafshede P. ATP7A-regulated enzyme metalation and trafficking in the menkes disease puzzle. Biomedicines. 2021;9(4):391.","journal-title":"Biomedicines"},{"issue":"6","key":"1589_CR255","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.devcel.2014.04.033","volume":"29","author":"EV Polishchuk","year":"2014","unstructured":"Polishchuk EV, Concilli M, Iacobacci S, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell. 2014;29(6):686\u2013700.","journal-title":"Dev Cell"},{"issue":"8","key":"1589_CR256","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036863","volume":"10","author":"JH Cha","year":"2020","unstructured":"Cha JH, Chan LC, Song MS, Hung MC. New approaches on cancer immunotherapy. Cold Spring Harb Perspect Med. 2020;10(8): a036863.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"1589_CR257","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29(1):83.","journal-title":"J Biomed Sci"},{"issue":"12","key":"1589_CR258","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363.","journal-title":"Nat Cancer"},{"issue":"1","key":"1589_CR259","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13578-022-00948-7","volume":"12","author":"A Jiang","year":"2022","unstructured":"Jiang A, Luo P, Chen M, et al. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell Biosci. 2022;12(1):209.","journal-title":"Cell Biosci"},{"issue":"5","key":"1589_CR260","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388.","journal-title":"Nat Rev Clin Oncol"},{"key":"1589_CR261","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s11658-024-00608-3","volume":"29","author":"L Li","year":"2024","unstructured":"Li L, Zhou H, Zhang C. Cuproptosis in cancer: biological implications and therapeutic opportunities. Cell Mol Biol Lett. 2024;29:91.","journal-title":"Cell Mol Biol Lett"},{"key":"1589_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Update. 2024;72: 101018.","journal-title":"Drug Resist Update"},{"issue":"1","key":"1589_CR263","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-2007-967203","volume":"27","author":"R Xu","year":"2007","unstructured":"Xu R, Bu-Ghanim M, Fiel MI, Schiano T, Cohen E, Thung SN. Hepatocellular carcinoma associated with an atypical presentation of Wilson\u2019s disease. Semin Liver Dis. 2007;27(1):122\u20137.","journal-title":"Semin Liver Dis"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01589-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-024-01589-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-024-01589-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:03:32Z","timestamp":1723788212000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-024-01589-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":263,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1186\/s13045-024-01589-8","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}